title: Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.
authors.affiliation: Department of Surgery, UCLA Medical Center, Los Angeles, CA Department of Pathology and Laboratory Medicine, UCLA Medical Center, Los Angeles, CA Division of Digestive Diseases, UCLA Medical Center, Los Angeles, CA Department of Surgery, UCLA Medical Center, Los Angeles, CA, tdonahue@mednet.ucla.edu.
authors.forename: Motokazu
authors.initials: M
authors.lastname: Sugimoto
authors.forename: O Joe
authors.initials: OJ
authors.lastname: Hines
authors.forename: David W
authors.initials: DW
authors.lastname: Dawson
authors.forename: V Raman
authors.initials: VR
authors.lastname: Muthusamy
authors.forename: Howard A
authors.initials: HA
authors.lastname: Reber
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Donahue
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D018267:Carcinoma, Acinar Cell / Q000628:therapy*; D018273:Carcinoma, Islet Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D000077146:Irinotecan; D007813:Laparotomy / Q000379:methods*; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010179:Pancreas / Q000187:drug effects / Q000473:pathology / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000628:therapy*; D016577:Pancreaticoduodenectomy / Q000379:methods*; D057234:Preoperative Period; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin